TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4855695
log Bayes Factor = <0.0001
Chromosome 3   position 108,851,484  (GRCh37) Explore rs4855695 on Ensembl!
Variant rs4855695 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I25.1 Atherosclerotic heart disease
0.000 0.884 0.116
I25 Chronic ischaemic heart disease
0.000 0.898 0.102
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.898 0.102
I25.2 Old myocardial infarction
0.000 0.903 0.097
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.931 0.068
I25.4 Coronary artery aneurysm
0.000 0.933 0.067
I25.6 Silent myocardial ischaemia
0.000 0.939 0.060
I25.3 Aneurysm of heart
0.000 0.941 0.059
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.943 0.057
I25.5 Ischaemic cardiomyopathy
0.000 0.959 0.041
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.962 0.038
I20-I25 Ischaemic heart diseases
0.000 0.963 0.037
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.964 0.036
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.966 0.034
Y41.0 Sulphonamides
0.000 0.966 0.034
Y41.5 Antiviral drugs
0.000 0.966 0.034
Y42.7 Androgens and anabolic congeners
0.000 0.966 0.034
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.966 0.034
I21.0 Acute transmural myocardial infarction of anterior wall
0.000 0.967 0.033
Y54.3 Benzothiadiazine derivatives
0.000 0.967 0.033
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.967 0.033
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.968 0.032
Y44 Agents primarily affecting blood constituents
0.000 0.968 0.032
Y45.2 Propionic acid derivatives
0.000 0.969 0.031
I21 Acute myocardial infarction
0.000 0.969 0.031
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.970 0.030
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.971 0.029
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.972 0.028
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.972 0.028
I24 Other acute ischaemic heart diseases
0.000 0.972 0.028
Y41.1 Antimycobacterial drugs
0.000 0.972 0.027
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.973 0.027
Y41.4 Anthelminthics
0.000 0.973 0.027
Y41.3 Other antiprotozoal drugs
0.000 0.973 0.027
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.973 0.027
Y48 Anaesthetics and therapeutic gases
0.000 0.973 0.027
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.973 0.027
Y42.1 Thyroid hormones and substitutes
0.000 0.973 0.027
Y45.0 Opioids and related analgesics
0.000 0.974 0.026
I20 Angina pectoris
0.000 0.974 0.026
Y44.2 Anticoagulants
0.000 0.974 0.026
Y42.4 Oral contraceptives
0.000 0.974 0.026
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.974 0.026
I20.0 Unstable angina
0.000 0.974 0.026
Y54.7 Agents affecting calcification
0.000 0.974 0.025
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.974 0.026
Y44.5 Thrombolytic drugs
0.000 0.975 0.025
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.975 0.025
Y45.5 4-Aminophenol derivatives
0.000 0.975 0.025
I21.9 Acute myocardial infarction, unspecified
0.000 0.975 0.025
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.975 0.025
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.975 0.024
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.976 0.024
Y58 Bacterial vaccines
0.000 0.976 0.024
I23 Certain current complications following acute myocardial infarction
0.000 0.976 0.024
Y49.2 Other and unspecified antidepressants
0.000 0.976 0.024
Y54.9 Mineral salts, not elsewhere classified
0.000 0.977 0.023
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.977 0.023
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.977 0.023
Y54.0 Mineralocorticoids
0.000 0.977 0.023
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.977 0.023
Y42.5 Other oestrogens and progestogens
0.000 0.977 0.023
Y45.4 Antirheumatics
0.000 0.977 0.023
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.977 0.023
Y59 Other and unspecified vaccines and biological substances
0.000 0.977 0.023
Y42.9 Other and unspecified hormone antagonists
0.000 0.977 0.023
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.977 0.023
Y44.7 Plasma substitutes
0.000 0.977 0.023
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.977 0.023
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.977 0.023
Y44.6 Natural blood and blood products
0.000 0.977 0.023
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.977 0.023
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.978 0.022
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.978 0.022
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.978 0.022
Y42.2 Antithyroid drugs
0.000 0.978 0.022
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.979 0.021
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.979 0.021
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.979 0.021
Y49.9 Psychotropic drug, unspecified
0.000 0.979 0.021
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.979 0.021
Y49.7 Psychostimulants with abuse potential
0.000 0.979 0.021
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.979 0.021
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.979 0.021
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.979 0.021
Y54.8 Agents affecting uric acid metabolism
0.000 0.979 0.021
Y54.5 Other diuretics
0.000 0.979 0.021
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.979 0.021
Y48.4 Anaesthetic, unspecified
0.000 0.979 0.021
Y43 Primarily systemic agents
0.000 0.979 0.021
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.979 0.020
Y48.3 Local anaesthetics
0.000 0.980 0.020
I20.1 Angina pectoris with documented spasm
0.000 0.980 0.020
Y49.5 Other antipsychotics and neuroleptics
0.000 0.980 0.020
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.980 0.020
Y46.4 Iminostilbenes
0.000 0.980 0.019
Y48.5 Therapeutic gases
0.000 0.980 0.019
Y48.1 Parenteral anaesthetics
0.000 0.980 0.019
Y48.0 Inhaled anaesthetics
0.000 0.980 0.019
Y48.2 Other and unspecified general anaesthetics
0.000 0.981 0.019
Y45.8 Other analgesics and antipyretics
0.000 0.981 0.019
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.981 0.019
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.981 0.019
I24.1 Dressler's syndrome
0.000 0.981 0.019
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.981 0.018
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.018
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.981 0.018
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.981 0.018
Y51.0 Anticholinesterase agents
0.000 0.981 0.018
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.982 0.018
Y54.4 Loop [high-ceiling] diuretics
0.000 0.982 0.018
Y40 Systemic antibiotics
0.000 0.982 0.018
Y43.4 Immunosuppressive agents
0.000 0.982 0.018
Y50.9 Central nervous system stimulant, unspecified
0.000 0.982 0.018
Y50.8 Other central nervous system stimulants
0.000 0.982 0.018
Y50.1 Opioid receptor antagonists
0.000 0.982 0.018
Y50.0 Analeptics
0.000 0.982 0.018
Y58.9 Other and unspecified bacterial vaccines
0.000 0.982 0.018
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.982 0.018
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.982 0.018
Y58.5 Diphtheria vaccine
0.000 0.982 0.018
Y58.4 Tetanus vaccine
0.000 0.982 0.018
Y58.3 Plague vaccine
0.000 0.982 0.018
Y58.2 Cholera vaccine
0.000 0.982 0.018
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.982 0.018
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.982 0.017
I22 Subsequent myocardial infarction
0.000 0.982 0.018
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.982 0.017
S42.20 Fracture of upper end of humerus (closed)
0.018 0.982 0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.982 0.017
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.982 0.017
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.982 0.017
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.982 0.017
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.000 0.982 0.017
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.982 0.017
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.982 0.017
Y57 Other and unspecified drugs and medicaments
0.000 0.983 0.017
Y58.0 BCG vaccine
0.000 0.983 0.017
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.983 0.017
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.983 0.017
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.983 0.017
Y47.4 Bromine compounds
0.000 0.983 0.017
Y47.3 Paraldehyde
0.000 0.983 0.017
Y47.2 Chloral derivatives
0.000 0.983 0.017
Y47.0 Barbiturates, not elsewhere classified
0.000 0.983 0.017
Y59.9 Vaccine or biological substance, unspecified
0.000 0.983 0.017
Y59.8 Other specified vaccines and biological substances
0.000 0.983 0.017
Y59.2 Protozoal vaccines
0.000 0.983 0.017
Y59.1 Rickettsial vaccines
0.000 0.983 0.017
Y59.3 Immunoglobulin
0.000 0.983 0.017
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.983 0.016
Y55.5 Anticommon cold drugs
0.000 0.983 0.016
Y55.3 Antitussives
0.000 0.983 0.016
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.983 0.016
Y55.0 Oxytocic drugs
0.000 0.983 0.016
Y46.8 Antispasticity drugs
0.000 0.983 0.016
Y46.3 Deoxybarbiturates
0.000 0.983 0.016
Y46.1 Oxazolidinediones
0.000 0.983 0.016
Y46.0 Succinimides
0.000 0.983 0.016
Z95.4 Presence of other heart-valve replacement
0.000 0.984 0.016
Y40.8 Other systemic antibiotics
0.000 0.984 0.016
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.984 0.016
Y43.0 Antiallergic and antiemetic drugs
0.000 0.984 0.016
Y43.2 Antineoplastic natural products
0.000 0.984 0.015
Y47.1 Benzodiazepines
0.000 0.984 0.015
Y59.0 Viral vaccines
0.000 0.985 0.015
Y46.7 Anti-Parkinsonism drugs
0.000 0.985 0.015
Y43.9 Primarily systemic agent, unspecified
0.000 0.985 0.015
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.985 0.015
Y43.6 Enzymes, not elsewhere classified
0.000 0.985 0.015
Y43.5 Acidifying and alkalising agents
0.000 0.985 0.015
Y56.3 Emollients, demulcents and protectants
0.000 0.985 0.015
Y46.5 Valproic acid
0.000 0.985 0.015
Y56.9 Topical agent, unspecified
0.000 0.985 0.015
Y56.8 Other topical agents
0.000 0.985 0.015
Y56.7 Dental drugs, topically applied
0.000 0.985 0.015
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.985 0.015
Y56.5 Ophthalmological drugs and preparations
0.000 0.985 0.015
Y56.2 Local astringents and local detergents
0.000 0.985 0.015
Y56.1 Antipruritics
0.000 0.985 0.015
Y46.6 Other and unspecified antiepileptics
0.000 0.985 0.015
Y57.9 Drug or medicament, unspecified
0.000 0.985 0.015
Y40.4 Tetracyclines
0.000 0.985 0.015
I23.8 Other current complications following acute myocardial infarction
0.000 0.985 0.015
D12.6 Colon, unspecified
0.015 0.985 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.985 0.015
Y53.4 Other laxatives
0.000 0.985 0.015
Y55.4 Expectorants
0.000 0.985 0.014
Y46.2 Hydantoin derivatives
0.000 0.985 0.014
I22.8 Subsequent myocardial infarction of other sites
0.000 0.986 0.014
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.986 0.014
Y45.1 Salicylates
0.000 0.986 0.014
Y43.1 Antineoplastic antimetabolites
0.000 0.986 0.014
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.986 0.014
Y53.7 Emetics
0.000 0.986 0.014
Y53.5 Digestants
0.000 0.986 0.014
Y53.3 Saline and osmotic laxatives
0.000 0.986 0.014
Y53.0 Histamine H2-receptor antagonists
0.000 0.986 0.014
Y53.2 Stimulant laxatives
0.000 0.986 0.013
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.986 0.014
Y40.7 Antifungal antibiotics, systemically used
0.000 0.986 0.013
Y40.2 Chloramphenicol group
0.000 0.987 0.013
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.987 0.013
Y57.7 Vitamins, not elsewhere classified
0.000 0.987 0.012
Y57.4 Pharmaceutical excipients
0.000 0.987 0.012
Y57.3 Alcohol deterrents
0.000 0.987 0.012
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.987 0.012
Y57.1 Lipotropic drugs
0.000 0.987 0.012
Y57.0 Appetite depressants [anorectics]
0.000 0.987 0.012
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.987 0.013
L85.9 Epidermal thickening, unspecified
0.013 0.987 0.000
Y53.6 Antidiarrhoeal drugs
0.000 0.988 0.012
F60.3 Emotionally unstable personality disorder
0.000 0.988 0.012
T92.5 Sequelae of injury of muscle and tendon of upper limb
0.000 0.988 0.012
F60 Specific personality disorders
0.000 0.988 0.012
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.988 0.012
Y40.6 Rifamycins
0.000 0.988 0.012
I21.4 Acute subendocardial myocardial infarction
0.000 0.988 0.012
I24.9 Acute ischaemic heart disease, unspecified
0.000 0.988 0.012
Y40.5 Aminoglycosides
0.000 0.988 0.011
T92.3 Sequelae of dislocation, sprain and strain of upper limb
0.000 0.989 0.011
Y57.8 Other drugs and medicaments
0.000 0.989 0.011
T92 Sequelae of injuries of upper limb
0.000 0.989 0.011
Y40.0 Penicillins
0.000 0.989 0.011
F10.3 Withdrawal state
0.011 0.989 0.000
L85.8 Other specified epidermal thickening
0.011 0.989 0.000
F60.9 Personality disorder, unspecified
0.000 0.989 0.011
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.989 0.011
T92.0 Sequelae of open wound of upper limb
0.000 0.990 0.010
L85 Other epidermal thickening
0.010 0.990 0.000
Y57.6 Other diagnostic agents
0.000 0.990 0.010
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.990 0.010
Z95 Presence of cardiac and vascular implants and grafts
0.000 0.990 0.010
T92.1 Sequelae of fracture of arm
0.000 0.990 0.010
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.990 0.010
F60.7 Dependent personality disorder
0.000 0.990 0.010
I20.9 Angina pectoris, unspecified
0.000 0.990 0.010
Z95.3 Presence of xenogenic heart valve
0.000 0.991 0.009
F60-F69 Disorders of adult personality and behaviour
0.000 0.991 0.009
F60.0 Paranoid personality disorder
0.000 0.991 0.009
F60.6 Anxious [avoidant] personality disorder
0.000 0.991 0.009
F60.5 Anankastic personality disorder
0.000 0.991 0.009
Z95.2 Presence of prosthetic heart valve
0.000 0.991 0.009
Y40.3 Macrolides
0.000 0.991 0.009
F60.8 Other specific personality disorders
0.000 0.991 0.009
F60.4 Histrionic personality disorder
0.000 0.991 0.009
F60.2 Dissocial personality disorder
0.000 0.991 0.009
F60.1 Schizoid personality disorder
0.000 0.991 0.009
T92.9 Sequelae of unspecified injury of upper limb
0.000 0.991 0.009
F69 Unspecified disorder of adult personality and behaviour
0.000 0.991 0.009
E78.0 Pure hypercholesterolaemia
0.000 0.991 0.009
T92.8 Sequelae of other specified injuries of upper limb
0.000 0.992 0.008
T90.4 Sequelae of injury of eye and orbit
0.000 0.992 0.008
S42.2 Fracture of upper end of humerus
0.008 0.992 0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified
0.000 0.992 0.008
F64 Gender identity disorders
0.000 0.992 0.008
Z50.2 Alcohol rehabilitation
0.008 0.992 0.000
F61 Mixed and other personality disorders
0.000 0.992 0.007
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb
0.000 0.992 0.007
Z95.1 Presence of aortocoronary bypass graft
0.000 0.992 0.008
L85.3 Xerosis cutis
0.007 0.992 0.000
L85.2 Keratosis punctata (palmaris et plantaris)
0.007 0.992 0.000
L85.0 Acquired ichthyosis
0.007 0.992 0.000
F68 Other disorders of adult personality and behaviour
0.000 0.993 0.007
T92.2 Sequelae of fracture at wrist and hand level
0.000 0.993 0.007
Y40.9 Systemic antibiotic, unspecified
0.000 0.993 0.007
F62 Enduring personality changes, not attributable to brain damage and disease
0.000 0.993 0.007
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.000 0.993 0.007
F65 Disorders of sexual preference
0.000 0.993 0.007
F63 Habit and impulse disorders
0.000 0.993 0.007
Z95.5 Presence of coronary angioplasty implant and graft
0.000 0.993 0.007
K11.2 Sialoadenitis
0.000 0.993 0.007
K74.6 Other and unspecified cirrhosis of liver
0.000 0.993 0.007
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris
0.007 0.993 0.000
F64.0 Transsexualism
0.000 0.993 0.007
T92.4 Sequelae of injury of nerve of upper limb
0.000 0.994 0.006
Y57.5 X-ray contrast media
0.001 0.994 0.006
C45.0 Mesothelioma of pleura
0.000 0.994 0.006
I20.8 Other forms of angina pectoris
0.000 0.994 0.006
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.994 0.006
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.000 0.994 0.006
S42.21 Fracture of upper end of humerus (open)
0.006 0.994 0.000
F64.9 Gender identity disorder, unspecified
0.000 0.994 0.006
F64.8 Other gender identity disorders
0.000 0.994 0.006
F64.2 Gender identity disorder of childhood
0.000 0.994 0.006
F64.1 Dual-role transvestism
0.000 0.994 0.006
D04.4 Skin of scalp and neck
0.006 0.994 0.000
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.994 0.005
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.000 0.994 0.006
C45 Mesothelioma
0.000 0.994 0.006
F68.8 Other specified disorders of adult personality and behaviour
0.000 0.994 0.005
F68.0 Elaboration of physical symptoms for psychological reasons
0.000 0.994 0.005
Z29.0 Isolation
0.000 0.994 0.006
Z95.0 Presence of cardiac pacemaker
0.000 0.994 0.006
L98.4 Chronic ulcer of skin, not elsewhere classified
0.000 0.994 0.006
D04.6 Skin of upper limb, including shoulder
0.005 0.995 0.000
C45.9 Mesothelioma, unspecified
0.000 0.995 0.005
T93 Sequelae of injuries of lower limb
0.000 0.995 0.005
T90 Sequelae of injuries of head
0.000 0.995 0.005
D04 Carcinoma in situ of skin
0.005 0.995 0.000
F62.9 Enduring personality change, unspecified
0.000 0.995 0.005
F62.8 Other enduring personality changes
0.000 0.995 0.005
F62.1 Enduring personality change after psychiatric illness
0.000 0.995 0.005
F62.0 Enduring personality change after catastrophic experience
0.000 0.995 0.005
F63.9 Habit and impulse disorder, unspecified
0.000 0.995 0.005
F63.8 Other habit and impulse disorders
0.000 0.995 0.005
F63.3 Trichotillomania
0.000 0.995 0.005
F63.2 Pathological stealing [kleptomania]
0.000 0.995 0.005
F63.1 Pathological fire-setting [pyromania]
0.000 0.995 0.005
F63.0 Pathological gambling
0.000 0.995 0.005
F65.9 Disorder of sexual preference, unspecified
0.000 0.995 0.005
F65.8 Other disorders of sexual preference
0.000 0.995 0.005
F65.6 Multiple disorders of sexual preference
0.000 0.995 0.005
F65.5 Sadomasochism
0.000 0.995 0.005
F65.4 Paedophilia
0.000 0.995 0.005
F65.3 Voyeurism
0.000 0.995 0.005
F65.2 Exhibitionism
0.000 0.995 0.005
F65.1 Fetishistic transvestism
0.000 0.995 0.005
F65.0 Fetishism
0.000 0.995 0.005
F66.9 Psychosexual development disorder, unspecified
0.000 0.995 0.005
F66.8 Other psychosexual development disorders
0.000 0.995 0.005
F66.2 Sexual relationship disorder
0.000 0.995 0.005
F66.1 Egodystonic sexual orientation
0.000 0.995 0.005
F66.0 Sexual maturation disorder
0.000 0.995 0.005
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.000 0.995 0.005
C45.7 Mesothelioma of other sites
0.000 0.995 0.005
K74.5 Biliary cirrhosis, unspecified
0.000 0.995 0.005
N34.3 Urethral syndrome, unspecified
0.005 0.995 0.000
D04.3 Skin of other and unspecified parts of face
0.005 0.995 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.000 0.995 0.005
T93.0 Sequelae of open wound of lower limb
0.000 0.995 0.005
K74 Fibrosis and cirrhosis of liver
0.000 0.995 0.005
D04.5 Skin of trunk
0.005 0.995 0.000
K11.6 Mucocele of salivary gland
0.000 0.995 0.005
K83.1 Obstruction of bile duct
0.000 0.995 0.005
Y52 Agents primarily affecting the cardiovascular system
0.001 0.995 0.004
R10.1 Pain localised to upper abdomen
0.000 0.995 0.005
T90.5 Sequelae of intracranial injury
0.000 0.995 0.004
L27.0 Generalised skin eruption due to drugs and medicaments
0.000 0.996 0.004
K74.3 Primary biliary cirrhosis
0.000 0.996 0.004
D04.7 Skin of lower limb, including hip
0.004 0.996 0.000
K11 Diseases of salivary glands
0.000 0.996 0.004
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
0.000 0.996 0.004
T96 Sequelae of poisoning by drugs, medicaments and biological substances
0.000 0.996 0.004
C45.2 Mesothelioma of pericardium
0.000 0.996 0.004
Q61.5 Medullary cystic kidney
0.004 0.996 0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.000 0.996 0.004
T93.4 Sequelae of injury of nerve of lower limb
0.000 0.996 0.004
D04.8 Skin of other sites
0.004 0.996 0.000
D04.0 Skin of lip
0.004 0.996 0.000
C45.1 Mesothelioma of peritoneum
0.000 0.996 0.004
Y52.7 Peripheral vasodilators
0.000 0.996 0.004
D04.1 Skin of eyelid, including canthus
0.004 0.996 0.000
T93.1 Sequelae of fracture of femur
0.000 0.996 0.004
T93.9 Sequelae of unspecified injury of lower limb
0.000 0.996 0.004
K11.9 Disease of salivary gland, unspecified
0.000 0.996 0.004
T90.3 Sequelae of injury of cranial nerves
0.000 0.996 0.004
T93.8 Sequelae of other specified injuries of lower limb
0.000 0.996 0.004
R90.0 Intracranial space-occupying lesion
0.000 0.996 0.004
D04.9 Skin, unspecified
0.004 0.996 0.000
D04.2 Skin of ear and external auricular canal
0.004 0.996 0.000
T91 Sequelae of injuries of neck and trunk
0.000 0.996 0.004
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.000 0.996 0.004
T90.1 Sequelae of open wound of head
0.000 0.996 0.004
S00.8 Superficial injury of other parts of head
0.000 0.996 0.004
T90.2 Sequelae of fracture of skull and facial bones
0.000 0.996 0.004
T98 Sequelae of other and unspecified effects of external causes
0.000 0.996 0.004
K74.4 Secondary biliary cirrhosis
0.000 0.996 0.003
K74.2 Hepatic fibrosis with hepatic sclerosis
0.000 0.996 0.003
K74.1 Hepatic sclerosis
0.000 0.996 0.003
T95 Sequelae of burns, corrosions and frostbite
0.000 0.996 0.003
D12.7 Rectosigmoid junction
0.004 0.996 0.000
T90.0 Sequelae of superficial injury of head
0.000 0.996 0.003
T91.9 Sequelae of unspecified injury of neck and trunk
0.000 0.996 0.004
K11.5 Sialolithiasis
0.000 0.996 0.004
Y52.8 Antivaricose drugs, including sclerosing agents
0.001 0.996 0.003
Q61 Cystic kidney disease
0.003 0.997 0.000
K11.4 Fistula of salivary gland
0.000 0.997 0.003
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.997 0.003
X78.0 Home
0.000 0.997 0.003
T94 Sequelae of injuries involving multiple and unspecified body regions
0.000 0.997 0.003
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.001 0.997 0.003
K11.7 Disturbances of salivary secretion
0.000 0.997 0.003
K11.3 Abscess of salivary gland
0.000 0.997 0.003
L02.1 Cutaneous abscess, furuncle and carbuncle of neck
0.000 0.997 0.003
I24.8 Other forms of acute ischaemic heart disease
0.000 0.997 0.003
K11.0 Atrophy of salivary gland
0.000 0.997 0.003
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
Q61.0 Congenital single renal cyst
0.003 0.997 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.001 0.997 0.002
T91.5 Sequelae of injury of intra-abdominal and pelvic organs
0.000 0.997 0.003
T91.4 Sequelae of injury of intrathoracic organs
0.000 0.997 0.003
T91.0 Sequelae of superficial injury and open wound of neck and trunk
0.000 0.997 0.003
K11.1 Hypertrophy of salivary gland
0.000 0.997 0.003
Q61.9 Cystic kidney disease, unspecified
0.003 0.997 0.000
Z93.1 Gastrostomy status
0.003 0.997 0.000
T91.8 Sequelae of other specified injuries of neck and trunk
0.000 0.997 0.003
F10 Mental and behavioural disorders due to use of alcohol
0.003 0.997 0.000
F10.9 Unspecified mental and behavioural disorder
0.003 0.997 0.000
D11.0 Parotid gland
0.000 0.997 0.003
T95.1 Sequelae of burn, corrosion and frostbite of trunk
0.000 0.997 0.003
T98.2 Sequelae of certain early complications of trauma
0.000 0.997 0.003
T98.0 Sequelae of effects of foreign body entering through natural orifice
0.000 0.997 0.003
C21.0 Anus, unspecified
0.000 0.997 0.003
D13.2 Duodenum
0.000 0.997 0.003
T90.8 Sequelae of other specified injuries of head
0.000 0.997 0.003
T98.1 Sequelae of other and unspecified effects of external causes
0.000 0.997 0.003
T95.9 Sequelae of unspecified burn, corrosion and frostbite
0.000 0.997 0.003
T95.8 Sequelae of other specified burn, corrosion and frostbite
0.000 0.997 0.003
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved
0.000 0.997 0.003
N34 Urethritis and urethral syndrome
0.003 0.997 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.000 0.997 0.003
Q61.3 Polycystic kidney, unspecified
0.003 0.997 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.001 0.997 0.002
Q61.2 Polycystic kidney, adult type
0.003 0.997 0.000
T90.9 Sequelae of unspecified injury of head
0.000 0.997 0.003
F10.4 Withdrawal state with delirium
0.003 0.997 0.000
Q61.8 Other cystic kidney diseases
0.003 0.997 0.000
Q61.1 Polycystic kidney, infantile type
0.003 0.997 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.997 0.003
T95.2 Sequelae of burn, corrosion and frostbite of upper limb
0.000 0.997 0.002
T95.0 Sequelae of burn, corrosion and frostbite of head and neck
0.000 0.997 0.002
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.000 0.997 0.003
C21.1 Anal canal
0.000 0.997 0.003
Q61.4 Renal dysplasia
0.002 0.997 0.000
T91.2 Sequelae of other fracture of thorax and pelvis
0.000 0.997 0.002
F10.7 Residual and late-onset psychotic disorder
0.003 0.997 0.000
F10.5 Psychotic disorder
0.003 0.997 0.000
K11.8 Other diseases of salivary glands
0.000 0.997 0.002
T91.3 Sequelae of injury of spinal cord
0.000 0.997 0.002
T91.1 Sequelae of fracture of spine
0.000 0.997 0.002
K04.9 Other and unspecified diseases of pulp and periapical tissues
0.000 0.997 0.003
N34.2 Other urethritis
0.002 0.997 0.000
N34.0 Urethral abscess
0.002 0.997 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.001 0.998 0.002
Y83.6 Removal of other organ (partial) (total)
0.000 0.998 0.002
T93.2 Sequelae of other fractures of lower limb
0.000 0.998 0.002
T94.0 Sequelae of injuries involving multiple body regions
0.000 0.998 0.002
T95.3 Sequelae of burn, corrosion and frostbite of lower limb
0.000 0.998 0.002
N34.1 Nonspecific urethritis
0.002 0.998 0.000
Y52.1 Calcium-channel blockers
0.001 0.998 0.002
Y87.1 Sequelae of assault
0.000 0.998 0.002
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.000 0.998 0.002
L72.8 Other follicular cysts of skin and subcutaneous tissue
0.002 0.998 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.000 0.998 0.002
F10.8 Other mental and behavioural disorders
0.002 0.998 0.000
F10.6 Amnesic syndrome
0.002 0.998 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.000 0.998 0.002
T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified
0.000 0.998 0.002
C21 Malignant neoplasm of anus and anal canal
0.000 0.998 0.002
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.000 0.998 0.002
C46 Kaposi's sarcoma
0.000 0.998 0.002
C49.6 Connective and soft tissue of trunk, unspecified
0.000 0.998 0.002
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.000 0.998 0.002
E78.4 Other hyperlipidaemia
0.000 0.998 0.002
X78 Intentional self-harm by sharp object
0.000 0.998 0.002
C48.0 Retroperitoneum
0.000 0.998 0.002
C49.5 Connective and soft tissue of pelvis
0.000 0.998 0.002
Y43.3 Other antineoplastic drugs
0.000 0.998 0.002
T94.1 Sequelae of injuries, not specified by body region
0.000 0.998 0.002
K74.0 Hepatic fibrosis
0.001 0.998 0.001
Y52.3 Coronary vasodilators, not elsewhere classified
0.001 0.998 0.001
D45 Polycythaemia vera
0.002 0.998 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.998 0.002
M72.27 Plantar fascial fibromatosis-Ankle/Foot
0.000 0.998 0.002
R90 Abnormal findings on diagnostic imaging of central nervous system
0.000 0.998 0.002
C49.1 Connective and soft tissue of upper limb, including shoulder
0.000 0.998 0.002
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung
0.000 0.998 0.002
C49.9 Connective and soft tissue, unspecified
0.000 0.998 0.002
M47.22 Other spondylosis with radiculopathy (Cervical region)
0.002 0.998 0.000
T78.2 Anaphylactic shock, unspecified
0.002 0.998 0.000
M79.00 Rheumatism, unspecified (Multiple sites)
0.000 0.998 0.002
C22.9 Liver, unspecified
0.000 0.998 0.002
Y87.2 Sequelae of events of undetermined intent
0.000 0.998 0.002
C49.8 Overlapping lesion of connective and soft tissue
0.000 0.998 0.002
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent
0.000 0.998 0.002
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.998 0.002
C21.2 Cloacogenic zone
0.000 0.998 0.002
C46.9 Kaposi's sarcoma, unspecified
0.000 0.998 0.002
C46.8 Kaposi's sarcoma of multiple organs
0.000 0.998 0.002
C46.7 Kaposi's sarcoma of other sites
0.000 0.998 0.002
C46.3 Kaposi's sarcoma of lymph nodes
0.000 0.998 0.002
C46.2 Kaposi's sarcoma of palate
0.000 0.998 0.002
C46.1 Kaposi's sarcoma of soft tissue
0.000 0.998 0.002
C46.0 Kaposi's sarcoma of skin
0.000 0.998 0.002
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.000 0.998 0.002
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.000 0.998 0.002
C47.6 Peripheral nerves of trunk, unspecified
0.000 0.998 0.002
C47.5 Peripheral nerves of pelvis
0.000 0.998 0.002
C47.4 Peripheral nerves of abdomen
0.000 0.998 0.002
C47.3 Peripheral nerves of thorax
0.000 0.998 0.002
C47.2 Peripheral nerves of lower limb, including hip
0.000 0.998 0.002
C47.1 Peripheral nerves of upper limb, including shoulder
0.000 0.998 0.002
C47.0 Peripheral nerves of head, face and neck
0.000 0.998 0.002
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.998 0.002
E78.1 Pure hyperglyceridaemia
0.000 0.998 0.002
R90.8 Other abnormal findings on diagnostic imaging of central nervous system
0.000 0.998 0.002
C21.8 Overlapping lesion of rectum, anus and anal canal
0.000 0.998 0.002
R82.7 Abnormal findings on microbiological examination of urine
0.002 0.998 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.